Ethyl myristate

CAS:
124-06-1
Family:
fatty acid ethyl ester
Also:
Ethyl myristate, Ethyl tetradecanoate, Ethyl tetradecanoate (ethyl myristate), ethyl tetradecanoate

Found heavily in (4 oils total)

Recorded sensory reference values
  • Affect valence: 0.25
  • Affect arousal: 0.15

Reference values depend on measurement conditions and do not describe an effective dose or the perception of a custom blend.

Ethyl tetradecanoate (ethyl myristate) is a aliphatic ethyl ester reported as a minor constituent in essential-oil GC-MS profiles.

Aroma and practical use

No aroma description is attached to this identity yet.

Reported benefits and effects

Findings retain their study context. An animal or laboratory result describes that experiment.

There are no constituent-specific outcome findings in this report. No therapeutic benefit is inferred from its presence.

Use concerns and concentration limits

Sensitization concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Phototoxicity concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Oxidation concernNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Penetration enhancementNot flagged

Not flagged in the current model. This is not proof of absence or unrestricted safety.

Model screening value100%

Screening assumption (unrestricted). It is not a verified constituent-specific exposure limit.

model fallback · No dedicated IFRA Standard found for ethyl tetradecanoate / ethyl myristate (CAS 124-06-1) in the IFRA Standards Index, 51st Amendment (2023)

Constituents it may interact with

No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.

What this report cannot establish

  • A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
  • The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
  • An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
  • A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
  • Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
  • Minor GC-MS constituent added during composition completion; same molecule as archive record ethyl-myristate (CAS 124-06-1); full profile/SEO detail still pending on this specific record.
  • No constituent-specific outcome findings are available in this report.
  • No cited aroma description is available for this identity.
  • No public source links are attached to this constituent report.
  • No constituent-specific numeric dermal reference is available here.